Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282 [Phase 3]

View source ↗

Summary

This document reports a Phase 3 clinical trial to evaluate the efficacy and safety of co-administration of AD-2281 and AD-2282 for Primary Hypercholesterolemia,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• AD-2281
• AD-2282

Snippet

Sponsor: Addpharma Inc. | Conditions: Primary Hypercholesterolemia | Phase 3 | Status: NOT_YET_RECRUITING